REGULATED PRESS RELEASE published on 12/01/2025 at 11:02, 9 months 7 days ago ENGIE announces financial close for its first offshore wind farm off the coast of Poland ENGIE, through Ocean Winds, achieves financial close for its first offshore wind farm, BC-Wind, in Poland's Baltic Sea, with 390 MW capacity, €2 billion financing, and strong local engagement ENGIE Offshore Wind Farm Poland Ocean Winds BC-Wind
PRESS RELEASE published on 12/01/2025 at 11:00, 9 months 7 days ago Original-Research: HausVorteil AG (von Parmantier & Cie. GmbH): Buy HausVorteil AG's scalable equity release business model already profitable with high demand and access to financing determining growth. For more details, download the research from PCR_HausVorteil_2025_12_01_EN Scalable Growth Profitable Business Model HausVorteil AG Equity Release Access To Financing
PRESS RELEASE published on 12/01/2025 at 10:30, 9 months 7 days ago artec technologies expands business in the Middle East: Sales office opened in Dubai and industry expert recruited locally artec technologies opens sales office in Dubai Media City and appoints industry expert Mark Barkey as head to strengthen presence in Middle East and expand network Middle East Dubai Artec Technologies Sales Office Mark Barkey
PRESS RELEASE published on 12/01/2025 at 10:05, 9 months 7 days ago Zentiva Expands into Biologics with the EU-Wide Launch of Its First Biosimilar Zentiva expands into biologics by launching its first biosimilar across Europe, aiming to enhance patient access to high-quality biological medicines Biosimilar Biologics Zentiva Patient Access EU-wide Launch
PRESS RELEASE published on 12/01/2025 at 10:00, 9 months 7 days ago Vossloh places €600 million promissory note loans Vossloh AG successfully completes €600 million promissory note loans placement, mainly for refinancing Sateba acquisition. Investor demand high with attractive terms Refinancing Investor Demand Promissory Note Loans Vossloh AG Sateba Acquisition
PRESS RELEASE published on 12/01/2025 at 09:49, 9 months 7 days ago Original-Research: Delticom AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY Research report issued by Quirin Privatbank Kapitalmarktgeschäft on Delticom AG, updating the recommendation to BUY with a target price of 3.80, expecting strong Q4 results and increased revenue forecast for 2025 Revenue Forecast Buy Recommendation Delticom AG Research Report Quirin Privatbank
PRESS RELEASE published on 12/01/2025 at 09:48, 9 months 7 days ago EQS-Adhoc: voestalpine AG: The Management Board of voestalpine AG resolves to use treasury shares to satisfy the subscription rights of the 2023 convertible bonds (if applicable) voestalpine AG Management Board resolves to use treasury shares to satisfy 2023 convertible bonds subscription rights. Details on share buyback program and disclosure obligations Share Buyback Convertible Bonds Treasury Shares Voestalpine AG Subscription Rights
PRESS RELEASE published on 12/01/2025 at 09:05, 9 months 7 days ago Medit recognized as the top brand in a global brand perception study by an external insights agency Medit recognized as the top brand in a global brand perception study by an external insights agency. Medit achieves highest overall brand perception score and positive sentiment rate among intraoral scanner brands analyzed Digital Dentistry Intraoral Scanner Global Study Medit Brand Perception Study
PRESS RELEASE published on 12/01/2025 at 09:05, 9 months 7 days ago Orqa Scales Production Capacity to 280,000 Drones, Eliminating Reliance on Chinese Drone Technology Orqa scales production capacity to 280,000 drones at its headquarters in Croatia, eliminating reliance on Chinese technology. The expansion meets growing demand for secure, defence-grade UAS systems Security Production Capacity European Drones Orqa
PRESS RELEASE published on 12/01/2025 at 09:05, 9 months 7 days ago BioNxt Signs Letter Agreement to Acquire 100% Interest in IP and to Codevelop a Sublingual Drug Formulation for Chemotherapy and Immunosuppressant Treatments BioNxt Solutions collaborates with European chemotherapy company for novel sublingual drug formulation with high-potency ingredient. Focus on oncology and immunosuppressant treatments. Company plans to expand IP portfolio Oncology BioNxt Solutions European Chemotherapy Company Sublingual Drug Formulation Immunosuppressant
Published on 09/09/2026 at 00:25, 8 minutes ago Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
Published on 09/08/2026 at 23:35, 58 minutes ago The Western Investment Company of Canada Limited Announces Intention to Commence Normal Course Issuer Bid
Published on 09/08/2026 at 22:30, 2 hours 3 minutes ago Grid Metals Announces Positive Mineralogical Results at Falcon West, Engages SGS Canada for Ore Sorting Test Work, and Announces Investor Relations Agreements
Published on 09/08/2026 at 22:15, 2 hours 18 minutes ago GameSquare Regains Compliance with Nasdaq's Minimum Bid Price Requirement
Published on 09/08/2026 at 22:05, 2 hours 28 minutes ago Loop Industries Appoints Jeff Geygan as Chairman of the Board
Published on 09/08/2026 at 22:50, 1 hour 43 minutes ago Cataneo Set to Unveil the Future of AI Engagement at IBC2026 in Amsterdam
Published on 09/08/2026 at 22:05, 2 hours 28 minutes ago oneworld Partners with Popular App Timeshifter to Help Round the World Travellers Beat Jet Lag
Published on 09/08/2026 at 18:30, 6 hours 3 minutes ago Avolta extends long-term travel retail contracts across four Mexican airports
Published on 09/08/2026 at 18:20, 6 hours 13 minutes ago Rönesans Named Among the World's Top 50 International Contractors for the 11th Consecutive Year
Published on 09/08/2026 at 11:00, 13 hours 33 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 09/08/2026 at 10:21, 14 hours 12 minutes ago Disclosure of Share Capital and Voting Rights as of August 31, 2026
Published on 09/07/2026 at 19:00, 1 day 5 hours ago Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 1 day 6 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026